Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low density lipoprotein receptor (LDLR) at the cell surface and disrupts the normal recycling of the LDLR. In this study, we investigated the role of the C-terminal domain for the activity of PCSK9. Experiments in which conserved residues and histidines on the surface of the C-terminal domain were mutated indicated that no specific residues of the C-terminal domain, apart from those responsible for maintaining the overall structure, are required for the activity of PCSK9. Rather, the net charge of the C-terminal domain is important. The more positively charged the C-terminal domain, the higher the activity toward the LDLR. Moreover, replacement of the C-terminal domain with ...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs mem-brane-bo...
Biologic-based strategies to inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) show prom...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of low-density lipoprotei...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of the hepatic low-de...
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) post-transcriptionally degrades th...
Elevated LDL-cholesterol (LDLc) levels are a major risk factor for cardiovascular disease and athero...
The discovery that proprotein convertase subtilisin/kexin type 9 (PCSK9) mediates degradation of low...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted glycoprotein regulating the degr...
Circulating low-density lipoprotein cholesterol (LDLc) is regulated by membrane-bound LDL receptor (...
Genetic studies in humans and mice have demonstrated that proprotein convertase subtilisin/kexin typ...
SummaryProprotein convertase subtilisin kexin type 9 (PCSK9) has been shown to be involved in the re...
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) is the ninth member of the Ca+2-dependent mammalian...
The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is involved in the post-transcription...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs membrane-bou...
Mutations in the proprotein convertase PCSK9 gene are associated with autosomal dominant familial hy...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs mem-brane-bo...
Biologic-based strategies to inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) show prom...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of low-density lipoprotei...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of the hepatic low-de...
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) post-transcriptionally degrades th...
Elevated LDL-cholesterol (LDLc) levels are a major risk factor for cardiovascular disease and athero...
The discovery that proprotein convertase subtilisin/kexin type 9 (PCSK9) mediates degradation of low...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted glycoprotein regulating the degr...
Circulating low-density lipoprotein cholesterol (LDLc) is regulated by membrane-bound LDL receptor (...
Genetic studies in humans and mice have demonstrated that proprotein convertase subtilisin/kexin typ...
SummaryProprotein convertase subtilisin kexin type 9 (PCSK9) has been shown to be involved in the re...
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) is the ninth member of the Ca+2-dependent mammalian...
The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is involved in the post-transcription...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs membrane-bou...
Mutations in the proprotein convertase PCSK9 gene are associated with autosomal dominant familial hy...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs mem-brane-bo...
Biologic-based strategies to inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) show prom...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of low-density lipoprotei...